GlassScriptPhysician profile
Irene Minkoff
NPI 1427004142
$1,350.66
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,067 · 2020: $154 · 2021: $41.68 · 2023: $67.36 · 2024: $20.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $87.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $87.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $170.23 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $152.41 | 2019-2020 | |
| Akcea Therapeutics, INC. | $124.76 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $122.13 | 2019 | |
| Puma Biotechnology, INC. | $121.85 | 2019 | |
| Kite Pharma, INC. | $120.52 | 2019 | |
| Genzyme Corporation | $120.50 | 2019 | |
| Genentech USA, INC. | $98.21 | 2019 | |
| Merck Sharp & Dohme LLC | $56.77 | 2021-2023 | Lynparza, Welireg, Keytruda |
| Novartis Pharmaceuticals Corporation | $53.23 | 2019-2024 | |
| Astellas Pharma US INC | $40.24 | 2019 | |
| Tersera Therapeutics LLC | $33.13 | 2023 | Xermelo |
| Emd Serono, INC. | $21.72 | 2019 | |
| Janssen Pharmaceuticals, INC | $20.41 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $19.09 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $18.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.60 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $16.23 | 2019 | |
| Pfizer INC. | $13.47 | 2020 | |
| Clovis Oncology, INC. | $10.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irene Minkoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.